← Back to House of Commons Debates

NICE-Approved Products: Patient Access

30 November 2021

Lead MP

Anne Marie Morris

Debate Type

General Debate

Tags

NHSTaxation
Other Contributors: 3

At a Glance

Anne Marie Morris raised concerns about nice-approved products: patient access in the House of Commons. Other MPs contributed to the debate.

How the Debate Unfolded

MPs spoke in turn to share their views and ask questions. Here's what each person said:

Lead Contributor

Opened the debate
Rises to address the issue of access for patients to medicines and medical devices. Explains that when a medicine is approved, it goes through two processes: first with the MHRA for safety and efficacy, then NICE for cost-effectiveness. Argues that despite legal rights outlined in the NHS constitution, there are practical hurdles preventing full access, including postcode lottery issues due to formulary restrictions. Proposes solutions such as automatic inclusion of NICE-approved drugs on local health system formularies within 28 days, an innovation officer role, differential pricing for multi-indication approvals, and formal delivery mechanisms for managed access treatments.
Assessment & feedback
Summary accuracy

About House of Commons Debates

House of Commons debates take place in the main chamber of the House of Commons. These debates cover a wide range of topics including government policy, legislation, and current affairs. MPs from all parties can participate, question ministers, and hold the government accountable for its decisions.